IP Library › Granted Patent US 9,750,731
Granted Patent B2
US 9,750,731 · App. 14/465,644 · Granted Sep 5, 2017

Small molecules modulator of epigenetic regulation and their therapeutic applications

Inventors: Lin Chen (La Canada, CA); Nimanthi Jayathilaka (Los Angeles, CA); Aidong Han (Los Angeles, CA); Nicos Petasis (Hacienda Heights, CA)
Assignee: UNIVERSITY OF SOUTHERN CALIFORNIA
A61K31/444A61K31/00A61K31/167C07C233/43C07D213/40G01N33/6875C07K2299/00G01N2500/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,750,731
App. No.
14/465,644
Granted
Sep 5, 2017
Kind
B2
Abstract

Disclosed are methods and compositions for modulating the function of transcription factors, especially transcription factors that recruit epigenetic regulators (histone modifying enzymes) to specific DNA promoters. The targeted transcription factors include but are not limited to the myocyte enhancing factor (MEF2), the forkhead/winged helix transcription factor FOXP3 and the transcription factor GATA3. Also disclosed are small molecule modulators of MEF2 and its associated factors that include but not limited to histone deacetylases (HDACs), p300/CBP and Cabin1 and the therapeutic applications thereof.

Claims (1)

1. A compound having a formula:

Assignments (1)
CONFIRMATORY LICENSE Recorded Mar 25, 2015
From: UNIVERSITY OF SOUTHERN CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035280/0142 →
Continuity (5)
Continuation 13801380 · Mar 13, 2013
Division 12613521 · Nov 5, 2009
Provisional Application 61111689 · Nov 5, 2008
Provisional Application 61246934 · Sep 29, 2009
Related Publication 20150150860A1 · Jun 4, 2015